Bone Marrow Transplantation for Aplastic Anemia
The increased survival of aplastic anemia patients treated by human leukocyte antigens (HLA)-identical marrow transplants is due in part to a decrease in the incidence of graft rejection. The decrease in rejection, in turn, results from the more judicious use of transfusions before transplant, the r...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
1993-09-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/096368979300200503 |